BOSTON SCIENTIFIC CORPORATION (NYSE:BSX) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security
Holders.
(a) Boston Scientific Corporation (the Company) held its 2017
Annual Meeting of Stockholders (the Annual Meeting) on May9, 2017
at its Corporate Headquarters located in Marlborough,
Massachusetts.
(b) The final voting results on each of the matters submitted to
a vote of stockholders at the Annual Meeting are set forth below.
(1) All ten director nominees were elected to the Companys Board
of Directors for a one-year term to hold office until the
Companys 2018 Annual Meeting of Stockholders and until their
successors have been elected and qualified.
|
Nominee |
|
For |
|
Withheld |
|
BrokerNon-Votes |
|
|
Nelda J. Connors |
1,160,360,773 |
3,898,512 |
46,966,996 |
||||
|
Charles J. Dockendorff |
1,160,410,669 |
3,848,616 |
46,966,996 |
||||
|
Yoshiaki Fujimori |
1,160,410,929 |
3,848,356 |
46,966,996 |
||||
|
Donna A. James |
1,159,300,583 |
4,958,702 |
46,966,996 |
||||
|
Edward J. Ludwig |
1,158,566,976 |
5,692,309 |
46,966,996 |
||||
|
Stephen P. MacMillan |
1,159,538,636 |
4,720,649 |
46,966,996 |
||||
|
Michael F. Mahoney |
1,130,169,379 |
34,089,906 |
46,966,996 |
||||
|
David J. Roux |
1,160,896,524 |
3,362,761 |
46,966,996 |
||||
|
John E. Sununu |
1,155,148,097 |
9,111,188 |
46,966,996 |
||||
|
Ellen M. Zane |
1,159,361,108 |
4,898,177 |
46,966,996 |
(2) The advisory vote on the compensation for the Companys Named
Executive Officers as disclosed in the Companys proxy statement
for the Annual Meeting was approved.
|
For |
|
Against |
|
Abstain |
|
BrokerNon-Votes |
|
|
1,131,879,610 |
30,329,003 |
2,050,672 |
46,966,996 |
(3) The advisory vote on the frequency of an advisory vote to
approve the compensation of the Companys Named Executive
Officers.
|
OneYear |
|
TwoYears |
|
ThreeYears |
|
Abstain |
|
BrokerNon-Votes |
|
|
1,024,944,991 |
3,262,639 |
134,701,705 |
1,349,950 |
46,966,996 |
Based on the votes set forth above, the Companys stockholders
approved, on a non-binding, advisory basis, a frequency of One
Year for the non-binding, advisory vote on the compensation of
the Companys named executive officers. The Board of Directors
considered these voting results and other factors, and has
determined that the Company will hold future advisory votes on
its executive compensation on an annual basis.
(4) The appointment of Ernst Young LLP as the Companys
independent registered public accounting firm for the 2017 fiscal
year was ratified.
|
For |
|
Against |
|
Abstain |
|
|
1,199,107,187 |
10,976,016 |
1,143,078 |
About BOSTON SCIENTIFIC CORPORATION (NYSE:BSX)
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven core businesses: Interventional Cardiology, Peripheral Interventions (PI), Cardiac Rhythm Management (CRM), Electrophysiology (EP), Endoscopy, Urology and Pelvic Health, and Neuromodulation. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and PI businesses. Its Rhythm Management segment consists of CRM and EP businesses. Its MedSurg segment consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its interventional cardiology products include Drug-Eluting Coronary Stent Systems, Core Coronary Technology, Intravascular Imaging and Structural Heart Therapy. Its peripheral products include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters. BOSTON SCIENTIFIC CORPORATION (NYSE:BSX) Recent Trading Information
BOSTON SCIENTIFIC CORPORATION (NYSE:BSX) closed its last trading session down -0.09 at 26.37 with 4,490,466 shares trading hands.
